The product is intended for the removal of foreign material such as microorganisms and debris following dermal procedures.
“Within my practice I utilize the Microcyn Technology post-procedure and have been most impressed with its ability to accelerate the healing process, manage post-procedure symptoms and protect against secondary infections,” said Michael Gold, MD, a board-certified dermatologist and cosmetic surgeon.
Etaluma, Calif.-based Oculus plans to launch the dermatology product in the U.S. in March 2017.
More articles on supply chain:
Hillary Clinton calls on Mylan to lower EpiPen prices
Medical device, drug recalls soar in Q2
Medical device giant Medtronic takes over HeartWare for $1.1B
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
